Our role in the medical community is one we value very deeply. As a referral hospital we are a
collaborative partner, establishing and maintaining clear lines of
communications with referring physicians throughout treatment. We take
leadership roles in organizations that advance the way pediatric cancer and
blood disorders are treated around the globe. And our fellowship program
has trained more leaders in the pediatric hematology and oncology field than
any other. Continue reading to learn more, or contact us to refer a patient or request
a second opinion.
As a physician who
wants the best for your patients, you can feel confident entrusting their care
to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
Our program brings
together renowned hematologists and oncologists from Boston Children’s Hospital
and Dana-Farber Cancer Institute. Our faculty is comprised of internationally
recognized leaders, including David Williams, MD; Lisa Diller, MD; Lindsay Frazier, MD; Holcombe Grier, MD; Matthew Heeney, MD; Leslie Lehmann, MD; Karen Marcus, MD; Stephen Sallan, MD; Suzanne Shusterman, MD; and Lewis Silverman, MD; among others.
Our patients benefit
from a multidisciplinary team of physicians who specialize in treating children
and adolescents with cancer and blood disorders. We surround our specialists
with a vast community of pediatric subspecialists to provide your patient an unrivaled
breadth of expertise across disciplines, including nursing, pathology,
radiology, surgery, diagnostic imaging, neurology, and orthopedics. Psychological and emotional support is provided by
psychologists, child life specialists, and clinical social workers. The
spectrum and depth of care we provide, from diagnosis to survivorship, is
With over 200 active clinical trials at any given time, we are at the
forefront of innovation in the way pediatric cancer and blood disorders are
diagnosed and treated. Among our many trials are studies to develop innovative
therapies such as immunotherapy and gene
therapy. We are also a leader
in the integration of personalized medicine into treatment methodologies.
Our experts are
frequent speakers at conferences and seminars, including the annual meetings
for the American Society for Hematology (ASH), International Society of
Pediatric Oncology (SIOP), American Society of Pediatric Hematology/Oncology
(ASPHO), and the Society for Neuro-Oncology.
Hematology/Oncology Fellowship Program at Dana-Farber/Boston Children's is one
of the most recognized in the nation. This program has trained more leaders in
the hematology and oncology field than any other. The objective of the training
program is to provide the highest quality clinical and research training in
hematology/oncology, so that our fellows become excellent clinicians and
independent investigators making substantive contributions to biomedical
A genetic test can explain why a child or young adult developed cancer and can help to predict whether he/she is at risk for other cancers.
Patients with hemophilia and other bleeding disorders are treated at the Boston Hemophilia Center, the largest hemophilia program in New England.
Our survivorship program provides care and advocacy for survivors of childhood cancer through ongoing education, support, and research on the long-term effects of cancer treatments.
World class cancer care at the #1 children's hospital
Not only are we a world-class cancer and blood disorders center; we're also part of the top-ranked pediatric hospital. Above, our physicians explain how our vast clinical resources benefit patients.